Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
- 1 December 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 287 (6) , L1186-L1192
- https://doi.org/10.1152/ajplung.00170.2004
Abstract
The sensitivity to the fibrosis-inducing effect of bleomycin varies considerably from species to species, the reasons for which are unknown. The variability of the response in different strains of mice is well documented. Recent evidence indicates that the upregulated expression of cytokines and cytokine receptors may be involved. We evaluated the expression pattern of some cytokines and their receptors in C57Bl/6J bleomycin-sensitive and Balb/C bleomycin-resistant mice. Animals from both strains received, under ether anesthesia, either saline (50 μl) or bleomycin (0.1 U/50 μl) intratracheally. At various times after the treatment, the lungs were analyzed for cytokines and cytokine receptors by histochemistry and their mRNA by RNase protection assay. A significantly increased expression of TNF-α and IL-1β was observed in both strains. However, an upregulated lung expression for TNF-α and IL-1 receptors was observed in C57Bl/6J-sensitive animals only. This profile is evident from 63 h onward. In addition to TNF-α, bleomycin administration also resulted in the upregulated expression of TGF-β in the lungs of both strains at 8 h and in an enhanced expression of TGF-β receptors I and II in C57Bl/6J mice only. The upregulation of TGF-β receptor expression was preceded in this strain by an increased expression of IL-4, IL-13, and IL-13 receptor-α (at 8 h after bleomycin) and followed by an upregulation of gp130 and IL-6. The difference we observed in the cytokine receptor profile may offer an additional explanation for the different fibrogenic response of the two mouse strains to bleomycin.Keywords
This publication has 40 references indexed in Scilit:
- The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression?Pharmacology & Therapeutics, 2003
- Cyclosporin A Upmodulates Bleomycin-Induced Pulmonary Fibrosis in BALB/c MiceRespiration, 2002
- Human ?-thrombin stimulates proliferation of interferon-? differentiated, growth-arrested U937 cells, overcoming differentiation-related changes in expression of p21CIP1/WAF1 and cyclin D1Journal of Cellular Physiology, 2002
- LYMPHOKINES IN BLEOMYCIN-INDUCED LUNG INJURY IN BLEOMYCIN-SENSITIVE C57BL/6 AND-RESISTANT BALB/c MICEExperimental Lung Research, 2000
- Interleukin-1Cytokine & Growth Factor Reviews, 1997
- Early and Persistent Alterations in the Expression of Interleukin-1α, Interleukin-1β and Tumor Necrosis Factor α mRNA Levels in Fibrosis-Resistant and Sensitive Mice after Thoracic IrradiationRadiation Research, 1996
- Co‐expression of TNFα and IL‐1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysisPathology International, 1996
- Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in miceEuropean Respiratory Journal, 1994
- Lung Cytokine Production in Bleomycin-Induced Pulmonary FibrosisExperimental Lung Research, 1992
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.The Journal of Experimental Medicine, 1989